Treatment Of Kidney Cancer

Treatment is tailored to the needs of the patient and this is dependent on the cancer staging in a particular patient. This way the most appropriate therapy can be chosen for the patient with the highest probability of cancer rate survival. Here are some typical survival figures for kidney cancer.  The best treatment for stage I and II is surgical removal of the affected kidney (nephrectomy).

In stage III this is combined with radiotherapy of the affected lymph glands in the regional area. Once the cancer has spread beyond the kidney border, metastases threaten to kill the patient (Ref. 2).

There is an FDA approved non-drug method available, IceWave patches from Lifewave, which will control pain. This is mentioned in the book "Breakthrough" by Suzanne Somers (Ref. 11) where newer insights of antiaging medicine are also reviewed. Although the patches are placed over acupuncture points, there are no needles involved. Nanotechnology, a newer technology, was used in the manufacturing of these patches and infrared (heat) waves from body heat are utilized to stimulate an acupuncture point, which modifies pain perception and reduces pain to half or less. Medically this would be considered an excellent pain reliever. For more info on the patches see the IceWave patches from Lifewave link above (click "products"). In the US a 5 pack of the IceWave spray is available that can be directly sprayed onto the skin in the area where the pain is located.

5-year survival rates for kidney cancer
 Stage:Survival Rate:Comments:
I85 %radical nephrectomy
II80 %radical nephrectomy
III50 %radical nephrectomy + radiotherapy of LN *
IV20 %high dose IL-2 therapy
* LN stands for lymph node metastases

Many different systemic therapies have been attempted in order to help the end stage patient.

However, chemotherapy only leads to partial responses for about 10 months irregardless of the agents used. Interferon has been disappointing. Another approach is the use of an immunostimulant, called interleukin-2 (IL-2). This tends to give response rates in stage IV kidney cancer patients of about 20% with cures of 5%. With tumor infiltrating leukocytes (TIL) amplified by IL-2 the cure rate has been observed to be as high as 30% in these patients.

Home Page Cancer Overview Kidney Cancer

 

 

 

Disclaimer:

This outline is only a teaching aid to patients and should stimulate you to ask the right questions when seeing your doctor. However, the responsibility of treatment stays in the hands of your doctor and you.

References:

1. Cancer: Principles &Practice of Oncology.4th edition. Edited by Vincent T. DeVita, Jr. et al. Lippincott, Philadelphia,PA, 1993. Chapter on Cancer of the kidney and ureter.

2. Cancer: Principles&Practice of Oncology. 5th edition, volume 1. Edited by Vincent T. DeVita, Jr. et al. Lippincott-Raven Publ., Philadelphia,PA, 1997. Chapter on Cancer of the kidney and ureter.

3. D Baris et al. Am J Ind Med 2001 May;39(5):463-476.

4. A Heiser et al. Cancer Res 2001 Apr 15;61(8):3388-3393.

5. A Gati et al. Cancer Res 2001 Apr 15;61(8):3240-3244.

6. P Lissoni et al. Anticancer Res 2001 Jan-Feb;21(1B):777-779.

7. X Guo et al. Cancer Res 2001 Mar 15;61(6):2774-2781.

8. A Bergstrom et al. Int J Cancer 2001 Apr 1;92(1):155-157.

9. Conn's Current Therapy 2004, 56th ed., Copyright © 2004 Elsevier

10. Ferri: Ferri's Clinical Advisor: Instant Diagnosis and Treatment, 2004 ed., Copyright © 2004 Mosby, Inc

11. Suzanne Somers: "Breakthrough" Eight Steps to Wellness-- Life-altering Secrets from Today's Cutting-edge Doctors", Crown Publishers, 2008

Last Modified: June 20, 2009